Page last updated: 2024-11-07

2-acetylaminofluorene and Leukemia L5178

2-acetylaminofluorene has been researched along with Leukemia L5178 in 3 studies

2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.

Leukemia L5178: An experimental lymphocytic leukemia of mice.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oberly, TJ1
Piper, CE1
McDonald, DS1
Amacher, DE1
Paillet, SC1
Elliott, JA1
Rogers, AM1
Hill, R1
Lehmann, AR1
Arlett, CF1
Burns, VW1

Other Studies

3 other studies available for 2-acetylaminofluorene and Leukemia L5178

ArticleYear
Metabolic activation capabilities of S9 liver fraction from 3 species in the L5178Y mouse-lymphoma assay.
    Mutation research, 1982, Volume: 105, Issue:6

    Topics: 2-Acetylaminofluorene; 9,10-Dimethyl-1,2-benzanthracene; Animals; Biotransformation; Cricetinae; Leu

1982
The metabolism of N-acetyl-2-aminofluorene to a mutagen in L5178Y/TK+/-mouse lymphoma cells.
    Mutation research, 1981, Volume: 89, Issue:4

    Topics: 2-Acetylaminofluorene; Animals; Biotransformation; Dose-Response Relationship, Drug; Leukemia L5178;

1981
The induction and characterization of mouse lymphoma L5178Y cell lines resistant to 1-beta-d-arabinofuranosylcytosine.
    Mutation research, 1980, Volume: 69, Issue:1

    Topics: 2-Acetylaminofluorene; Animals; Cell Line; Cytarabine; Drug Resistance; Ethidium; Ethyl Methanesulfo

1980